Cerebral Rhizomucor Infection Treated by Posaconazole Delayed-Release Tablets in an Allogeneic Stem Cell Transplant Recipient

Highlights • Mucormycosis (zygomycosis) is an emerging fungal disease in allogeneic hematopoietic stem cell transplant recipients. • Higher posaconazole plasma concentration might be obtained with posaconazole delayed-release tablets.

Saved in:
Bibliographic Details
Published in:International journal of infectious diseases 2017-02, Vol.55 (C), p.24-26
Main Authors: ANDREY, Diego O, KAISER, Laurent, EMONET, Stephan, ERARD, Veronique, CHALANDON, Yves, DELDEN, Christian VAN
Format: Article
Language:English
Subjects:
Adult
Antifungal Agents - therapeutic use
Delayed-Action Preparations
Fatal Outcome
Female
Humans
Immunocompromised Host
Infectious Disease
Leukemia, Myelomonocytic, Acute - immunology
Leukemia, Myelomonocytic, Acute - surgery
Mucormycosis
Mucormycosis - diagnosis
Mucormycosis - drug therapy
Mucormycosis - immunology
Mucormycosis - microbiology
Posaconazole delayed-release tablets
Pulmonary/Respiratory
Rhizomucor - drug effects
Rhizomucor pusillus
Stem Cell Transplantation
Tablets
Transplantation, Homologous
Triazoles - therapeutic use
Zygomycosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • Mucormycosis (zygomycosis) is an emerging fungal disease in allogeneic hematopoietic stem cell transplant recipients. • Higher posaconazole plasma concentration might be obtained with posaconazole delayed-release tablets.
ISSN:1201-9712
1878-3511
DOI:10.1016/j.ijid.2016.12.014